Neuroprotective natural products

Show results for

Unknown (228)
Transcriptomics (35)
Proteomics (10)
Genomics (5)
Metabolomics (5)

Organisms

Mus musculus (20)
Rattus norvegicus (8)
Homo sapiens (7)
Schizophyllum commune H4-8 (2)
Mycobacterium tuberculosis SP7 (2)
Salmonella enterica subsp. enterica serovar Typhimurium str. T000240 (2)
Oryza sativa Japonica Group (2)
Rabbit calicivirus (2)
Crotalus durissus terrificus (2)
Eriocheir sinensis (2)
Candidatus Endoriftia persephonae (2)
Mycobacterium tuberculosis SP10 (2)
Mycobacterium tuberculosis SP13 (2)
Cotesia typhae (2)
Mycobacterium tuberculosis SP22 (2)
Cepaea nemoralis (2)
Enterobacter ludwigii (2)
Trichoderma asperellum CBS 433.97 (2)
Corynebacterium diphtheriae bv. mitis str. ISS 3319 (2)
Nakaseomyces glabratus (2)
Olea europaea (2)
Mumps virus strain Enders (2)
Chlamydomonas reinhardtii (2)
Deinococcus deserti VCD115 (2)
Lama (2)
Planorbella pilsbryi (2)
Paradendryphiella salina (2)
Wolbachia sp. wMelPop (2)
Pyricularia oryzae P131 (2)
Drosophila melanogaster (1)

Repository

biostudies-arrayexpress (36)
MassIVE (8)
MetaboLights (4)
ENA (4)
pride (2)
GNPS (1)

Tissue

Brain (1)

Disease

Nurr1 lentivirus (1)

Technology Type

Mass spectrometry (3)
Mass Spectrometry (2)
Mass spectrometry assay (1)
Bottom-up proteomics (1)
Data-dependent acquisition (1)
Shotgun proteomics (1)

Instrument Platform

LTQ Orbitrap Velos (5)
Liquid Chromatography MS - negative - reverse phase (2)
Illumina NovaSeq X (1)
Xevo G2 Q-Tof (1)
LTQ Orbitrap XL (1)
Orbitrap Fusion Lumos (1)
Q Exactive (1)
Liquid Chromatography Tandem MS (LC-MS/MS (Negative)) (1)
Liquid Chromatography Tandem MS (LC-MS/MS (Positive)) (1)
Liquid Chromatography MS - Negative (LC-MS (Negative)) (1)
Liquid Chromatography MS - Positive (LC-MS (Positive)) (1)
Liquid Chromatography MS - alternating - reverse-phase (1)
Liquid Chromatography MS - positive - reverse phase (1)

Publication Date

2010 (6)
2008 (5)
2017 (4)
2015 (4)
2014 (4)
2011 (4)
2019 (4)
2026 (3)
2012 (3)
2009 (3)
2016 (2)
2013 (2)
2007 (2)
2020 (2)
2025 (2)
2023 (1)

CHEBI ID

CHEBI:134600 (1)
CHEBI:143239 (1)
CHEBI:143240 (1)
CHEBI:30985 (1)
CHEBI:143226 (1)
CHEBI:143242 (1)
CHEBI:143248 (1)
CHEBI:143244 (1)
CHEBI:143241 (1)
CHEBI:32811 (1)
CHEBI:27398 (1)
CHEBI:88543 (1)
CHEBI:143251 (1)
CHEBI:89901 (1)
CHEBI:143236 (1)
CHEBI:143237 (1)
CHEBI:17604 (1)
CHEBI:74112 (1)
CHEBI:68566 (1)
CHEBI:139272 (1)
CHEBI:53003 (1)
CHEBI:32354 (1)
CHEBI:62318 (1)
CHEBI:132244 (1)
CHEBI:89234 (1)
CHEBI:89621 (1)
CHEBI:143250 (1)
CHEBI:143247 (1)
CHEBI:87986 (1)
CHEBI:22652 (1)

Metabolite Name

N-Acetyl-aminooctanoic acid (1)
DL-alpha-Aminosuberic acid (1)
L-4-Hydroxyglutamate (1)
DL-beta-leucine (1)
Imidazole acetaldehyde (1)
3-(4-Hydroxyphenyl)propionic acid (1)
2-[4,6-Bis(2,4-dimethylphenyl)-1,3,5-triazin-2-yl]-5-(octyloxy)phenol (1)
D-aspartic acid (1)
Ascorbic acid-2-sulfate (1)
Adhumulone (1)
Glycerophospho-N-palmitoyl ethanolamine (1)
LysoPE(16:0/0:0) (1)
13-Hydroxyabscisic acid (1)
2-Hydroxyethanesulfonate (1)
Cysteineglutathione disulfide (1)
12-Ketodeoxycholic acid (1)
3-Methylglutaric acid (1)
Indole-3-lactic acid (1)
Orotic acid (1)
Indole-3-carboxilic acid-O-sulphate (1)
Noradrenochrome o-semiquinone (1)
Ascorbate (1)
Norophthalmic acid (1)
Daminozide (1)
3-Hydroxyvaleric acid (1)
12,13-DiHOME (1)
Taurohyocholate (1)
4-Hydroxy-6-methyl-2-pyrone (1)
13-OxoODE (1)
2'-Deoxyuridine (1)

First Public Date

2026 (2)
2025 (1)
2023 (1)

Study type

Transcription profiling by array (27)
RNA-seq of coding RNA (3)
Unknown experiment type (2)
Transcription profiling by RT-PCR (2)
ChIP-seq (1)
CUT&RUN (1)

Release Date

2025 (37)
2023 (36)
2022 (36)
2020 (25)
2024 (21)
2021 (21)
2019 (13)
2026 (10)
2016 (9)
2018 (9)
2014 (7)
2011 (7)
2010 (7)
2017 (6)
2015 (5)
2008 (5)
2012 (3)
2009 (3)
2013 (2)
2007 (2)

Lab affiliation

Istituto Zooprofilattico Sperimentale delle Venezie SCS2 - Dept. of Chemistry Italy (1)
Department of Chemical and Biological Engineering, The Hong Kong University of Science and Technology (HKUST) (1)

Tags

xref:EuropePMC:PMC13406071 (1)

Previous page
1 / 29
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 29
Next page

Sort by:

Relevance

Page size

Natural Products Inhibitors of Monoamine Oxidases-Potential New Drug Leads for Neuroprotection, Neurological Disorders, and Neuroblastoma.

Not available

S-EPMC9268457 | biostudies-literature

The small heat shock protein Alpha-Crystallin B shows neuroprotective properties in a glaucoma animal model

Aim of this study was the evaluation of Alpha-crystallin B and its potential neuroprotective properties in an experimentalanimal model of glaucoma with subsequent analysis of possible altered downstream markers in a complex mass spectrometric approach.

ORGANISM(S): Rattus Norvegicus (ncbitaxon:10116)

2017-11-28 | MSV000081755 | MassIVE

Identification of Neuroprotective Spoxazomicin and Oxachelin Glycosides via Chemoenzymatic Glycosyl-Scanning.

Not available

S-EPMC5337260 | biostudies-literature

Polyphyletic screen defines distinct classes of plant-derived natural products that oppose tauopathy.

Not available

S-EPMC12623141 | biostudies-literature

Transcription profiling of mouse ADNP knockout vs wild type

The putative transcription factor, activity-dependent neuroprotective protein (ADNP) is a zinc finger and homeodomain - like profile containing protein. ADNP knockout mice die at day 9 of gestation. To reveal ADNP-associated pathways, a 22,690- Affymetrix probe array was used on ADNP knockout and co...

ORGANISM(S): Mus musculus

2008-06-12 | E-GEOD-4068 | biostudies-arrayexpress

An Integrative Approach to Identifying Neuroprotective Natural Compounds for Neurodevelopmental Disorders.

Not available

S-EPMC12470177 | biostudies-literature

Aglodorols A-J, undescribed terpenoids with multidimensional neuroprotective activities from Aglaia odorata Lour.

Not available

S-EPMC12783399 | biostudies-literature

Magnolia officinalis (L.) Bark Extract Counteracts Oxidative Brain In-jury: A Proteomic Investigation into Neuroprotective Mechanisms

Neurodegenerative diseases involve progressive neuronal loss associated with oxidative stress (OS) and inflammation. Given the limited efficacy of current therapies, natural compounds with multitarget neuroprotective potential are of growing interest. In this study, we investigated the neuroprotecti...

ORGANISM(S): Rattus norvegicus (Rat)

2026-05-25 | PXD075711 | Pride

Neuroprotective effects of chemical constituents from Nicotiana tabacum L. in Parkinson's disease.

Not available

S-EPMC12484522 | biostudies-literature

Neurological disorders of COVID-19: insights to applications of natural products from plants and microorganisms.

Not available

S-EPMC9702705 | biostudies-literature

Previous page
1 / 29
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 29
Next page

Sort by:

Relevance

Page size

283 Results

Show results for

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

First Public Date

Study type

Release Date

Lab affiliation

Tags

OmicsDI is part of the ELIXIR infrastructure

Tweets